Shire’s SHP647 Shows Promise as Potential Ulcerative Colitis Treatment, Study Finds
News
Treatment with SHP647 (also known as PF-00547659) significantly decreased remission rates in a Phase 2 clinical trial of patients with ulcerative colitis, a type of inflammatory bowel disease (IBD). The ... Read more